(Q38539464)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Small conjugate-based theranostic agents: an encouraging approach for cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sankarprasad Bhuniya

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

7

Jong Seung Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Rajesh Kumar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Weon Sup Shin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Won Young Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Seyoung Koo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

1 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

published in

Chemical Society Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

6670-6683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

Human cancer classification: a systems biology- based model integrating morphology, cancer stem cells, proteomics, and genomics

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Cancer's molecular sweet tooth and the Warburg effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Nanomaterials for theranostics: recent advances and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Molecular imaging with theranostic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Glutathione and its role in cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Prodrug-based intracellular delivery of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

A fluorescence off-on reporter for real time monitoring of gemcitabine delivery to the cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

An activatable theranostic for targeted cancer therapy and imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Design, synthesis, and biological evaluation of theranostic vitamin-linker-taxoid conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Thiol-inducible direct fluorescence monitoring of drug release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Chemistry and biology of reactive oxygen species in signaling or stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

An activatable prodrug for the treatment of metastatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Aggregation-induced emission

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Real-time monitoring of drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Biological evaluation of a novel doxorubicin-peptide conjugate for targeted delivery to EGF receptor-overexpressing tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Design, synthesis and biological evaluation of mitochondria targeting theranostic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Synthesis of rhodamine-labelled dieckol: its unique intracellular localization and potent anti-inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Visible Light Controlled Release of Anticancer Drug through Double Activation of Prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Site-specific and far-red-light-activatable prodrug of combretastatin A-4 using photo-unclick chemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Synthesis and characterization of a theranostic vascular disrupting agent for in vivo MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Gadolinium complex of DO3A-benzothiazole aniline (BTA) conjugate as a theranostic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Tetranuclear gadolinium(III) porphyrin complex as a theranostic agent for multimodal imaging and photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Alkoxyamines: toward a new family of theranostic agents against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Molecular and cellular characterization of the biological effects of ruthenium(II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Luminescent ruthenium complexes for theranostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

Gold(III) complexes containing N-heterocyclic carbene ligands: thiol "switch-on" fluorescent probes and anti-cancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5CS00224A

21 January 2018

Identifiers

DOI

10.1039/C5CS00224A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26118960%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference